2025 - Introduced
Alabama S.B. 161
  • Requires that non-opioid drugs approved by the FDA are included on the preferred drug list with terms of coverage that are no less restrictive than those given to opioids on the preferred drug list.
Medicaid Parity
Read Bill
2025 - Introduced
Arizona H.B. 2823
  • Ensures that a non-opioid drug approved by the FDA is not disadvantaged or discouraged with respect to coverage relative to an opioid for the treatment or management of pain on the state drug formulary.
Medicaid Parity
Read Bill
2025 - Introduced
Arkansas H.B.1186
  • Provides for equal access to non-opioid pain relief options alongside opioid treatments within Arkansas' Medicaid program.
Medicaid Parity
Read Bill
2025 - Introduced
Florida H.B. 1093/S.B. 1154
  • Prohibits Medicaid from imposing restrictive practices that disadvantage or discourage the use of non-opioid drugs for the treatment of pain relative to opioids, including by establishing utilization controls for a non-opioid that are more restrictive or more extensive than the least restrictive or extensive utilization controls for any opioid.
Medicaid Parity
Read House BillRead Senate Bill
2025 - Introduced
Illinois S.B.1238
  • Prohibits a health insurer from denying coverage of a non-opioid in favor of an opioid and requires that in establishing a drug formulary, health insurers must ensure a non-opioid is not disadvantaged or discouraged with respect to coverage of an opioid. The bill also allows the Illinois Department of Public Health to develop and publish non-opioid educational resources.
Medicaid ParityState Regulated Commercial ParityEducation
Read Bill
2025 - Introduced
Indiana H.B. 1358
  • Prohibits stricter coverage restrictions under Medicaid and the Children’s Health Insurance Program for FDA-approved non-opioids compared to opioids to treat or manage pain. The bill also prohibits health insurers and health maintenance organization contracts from applying greater coverage restrictions on non-opioid prescribed drugs than to opioid drugs.
Medicaid ParityState Regulated Commercial Parity
Read Bill
2025 - Introduced
Iowa HSF 151
  • Requires that a non-opioid drug approved by the FDA is not disadvantaged or discouraged with respect to Medicaid coverage relative to an opioid on the preferred drug list.
  • Prohibits health insurers from establishing utilization controls for non-opioid drugs approved by the FDA that are more restrictive or extensive than the least restrictive or extensive utilization controls for any opioid.
Medicaid ParityState Regulated Commercial Parity
Read Bill
2025 - Introduced
Kansas H.B. 2364
  • Prohibits Medicaid and state employee health insurers from requiring cost-sharing, or providing less favorable coverage, for non-opioid prescriptions compared to opioids.
Medicaid Parity
Read Bill
2025 - Introduced
Kentucky S.B.128
  • Prohibits Medicaid from denying coverage for a non-opioid in favor of an opioid or establishing more restrictive or extensive utilization controls for non-opioids than the least restrictive or extensive utilization controls for any opioid.
Medicaid Parity
Read Bill
2024 - Passed
Louisiana S.B. 224
  • Directs that the state Medicaid program may not impose more restrictive utilization controls for non-opioid drugs than for opioids.
  • Prohibits Medicaid managed care organizations from denying coverage for a non-opioid prescription prescribed for pain in favor of an opioid.
  • Directs the state to create education, awareness and technical assistance materials on the advantage of non-opioid drugs and provide assistance with grants that promote non-opioid pain drugs.
EducationMedicaid Parity
Read Bill
2025 - Introduced
Maryland H.B. 1013/S.B. 974
  • Prohibits prior authorization requirements, step therapy protocol, or fail-first protocol for a non-opioid that is more restrictive than requirements for an opioid.
Medicaid ParityState Regulated Commercial Parity
Read House BillRead Senate Bill
2025 - Introduced
Massachusetts H.1134/S.863
  • Mandates Medicaid from imposing restrictive practices that disadvantage or discourage the use of non-opioid drugs for the treatment of pain relative to opioid drugs. The bill also creates a comprehensive integrated care management strategy for chronic pain patients enrolled in Medicaid and requires the Center for Health Information & Analysis to issue a report every two years on the incidence and prevalence of chronic pain in Massachusetts.
Medicaid Parity
Read House BillRead Senate Bill